Becquemont, L <br/><br/>
Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jun 1997 
 - 619-27 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/S0009-9236(97)90095-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Area Under Curve<br/>Cholinesterase Inhibitors--blood<br/>Cross-Over Studies<br/>Cytochrome P-450 CYP1A2 Inhibitors<br/>Double-Blind Method<br/>Fluvoxamine--pharmacology<br/>Humans<br/>Male<br/>Reference Values<br/>Regression Analysis<br/>Selective Serotonin Reuptake Inhibitors--pharmacology<br/>Tacrine--blood